SCHEMBL23217017

SCHEMBL23217017

CC(C)(C)OC(=O)N1CCN(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.54
MAPT P10636 2/20 0.53
ALDH1A1 P00352 2/20 0.53
LMNA P02545 2/20 0.53
PDK2 Q15119 1/20 0.52
GPR119 Q8TDV5 6/20 0.50
TACR1 P25103 1/20 0.49
MAPK1 P28482 1/20 0.47
RAB9A P51151 1/20 0.47
ADRB1 P08588 1/20 0.46
NAMPT P43490 1/20 0.46
POLB P06746 1/20 0.46
MEN1 O00255 1/20 0.45
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MET P08581 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31252244 0.92 PHGDH (0.49) STSMAPTALDH1A1LMNAPDK2
SCHEMBL23228913 0.92 GPR119 (0.51) STSMAPTALDH1A1LMNAPDK2
SCHEMBL5341377 0.91 PHGDH (0.48) STSMAPTALDH1A1LMNAPDK2
SCHEMBL20567850 0.91 MAPT (0.48) STSMAPTALDH1A1LMNAPDK2
SCHEMBL23456298 0.90 STS (0.48) STSMAPTALDH1A1LMNAPDK2
SCHEMBL23456293 0.88 STS (0.49) STSMAPTALDH1A1LMNAPDK2
SCHEMBL28555679 0.87 MAPT (0.52) STSMAPTALDH1A1LMNAPDK2
SCHEMBL21542308 0.87 ALDH1A1 (0.65) MAPTALDH1A1LMNAGPR119MAPK1
SCHEMBL1459696 0.86 MAPT (0.64) MAPTALDH1A1LMNAPDK2GPR119
Piperazine SCHEMBL23217166 0.86 ADRB1 (0.46) STSMAPTALDH1A1LMNAPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124400-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2024-04-18 US disclosed
WO-2021072369-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2021-04-15 WO disclosed
WO-2021072369-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME DUKE UNIVERSITY (US) 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240124400-A1 LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME CFH, LPAR3, CBR3 STS 2771/4885MAPT 4754/4885ALDH1A1 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.